Back to top

Hikma advances $250m buyback, cuts share count and voting base

The latest update is out from Hikma Pharmaceuticals ( ($GB:HIK) ). Hikma Pharmaceuticals has continued the second tranche of its $250 million share...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Hikma Pharmaceuticals Plc (HKMPF)